Pharma & Healthcare
Global Targeting DNA Repair Drugs Market Research Report 2025
- Jun 01, 25
- ID: 284227
- Pages: 91
- Figures: 97
- Views: 8
The global market for Targeting DNA Repair Drugs was valued at US$ 783 million in the year 2024 and is projected to reach a revised size of US$ 2132 million by 2031, growing at a CAGR of 15.6% during the forecast period.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.
In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeting DNA Repair Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeting DNA Repair Drugs.
The Targeting DNA Repair Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeting DNA Repair Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeting DNA Repair Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Onxeo
FoRx Therapeutics
Artios Pharma Limited
Merck KGaA
Breakpoint Therapeutics
Luciole Pharmaceuticals
AstraZeneca
AbbVie
Johnson & Johnson
Pfizer
ClovisOncology
GlaxoSmithKline
Segment by Type
Olaparib
Rucaparib
Niraparib
Talazoparib
Others
Segment by Application
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Targeting DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Targeting DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.
In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeting DNA Repair Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeting DNA Repair Drugs.
The Targeting DNA Repair Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeting DNA Repair Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeting DNA Repair Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Onxeo
FoRx Therapeutics
Artios Pharma Limited
Merck KGaA
Breakpoint Therapeutics
Luciole Pharmaceuticals
AstraZeneca
AbbVie
Johnson & Johnson
Pfizer
ClovisOncology
GlaxoSmithKline
Segment by Type
Olaparib
Rucaparib
Niraparib
Talazoparib
Others
Segment by Application
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Targeting DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Targeting DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Targeting DNA Repair Drugs Market Overview
1.1 Product Definition
1.2 Targeting DNA Repair Drugs by Type
1.2.1 Global Targeting DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Olaparib
1.2.3 Rucaparib
1.2.4 Niraparib
1.2.5 Talazoparib
1.2.6 Others
1.3 Targeting DNA Repair Drugs by Application
1.3.1 Global Targeting DNA Repair Drugs Market Value by Application (2024 VS 2031)
1.3.2 Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Peritoneal Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Targeting DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global Targeting DNA Repair Drugs Revenue 2020-2031
1.4.2 Global Targeting DNA Repair Drugs Sales 2020-2031
1.4.3 Global Targeting DNA Repair Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Targeting DNA Repair Drugs Market Competition by Manufacturers
2.1 Global Targeting DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Targeting DNA Repair Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Targeting DNA Repair Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Targeting DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Targeting DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Targeting DNA Repair Drugs, Product Type & Application
2.7 Global Key Manufacturers of Targeting DNA Repair Drugs, Date of Enter into This Industry
2.8 Global Targeting DNA Repair Drugs Market Competitive Situation and Trends
2.8.1 Global Targeting DNA Repair Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Targeting DNA Repair Drugs Players Market Share by Revenue
2.8.3 Global Targeting DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Targeting DNA Repair Drugs Market Scenario by Region
3.1 Global Targeting DNA Repair Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Targeting DNA Repair Drugs Sales by Region: 2020-2031
3.2.1 Global Targeting DNA Repair Drugs Sales by Region: 2020-2025
3.2.2 Global Targeting DNA Repair Drugs Sales by Region: 2026-2031
3.3 Global Targeting DNA Repair Drugs Revenue by Region: 2020-2031
3.3.1 Global Targeting DNA Repair Drugs Revenue by Region: 2020-2025
3.3.2 Global Targeting DNA Repair Drugs Revenue by Region: 2026-2031
3.4 North America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.4.3 North America Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeting DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.5.3 Europe Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeting DNA Repair Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Targeting DNA Repair Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Targeting DNA Repair Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.7.3 Latin America Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Targeting DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeting DNA Repair Drugs Sales by Type (2020-2031)
4.1.1 Global Targeting DNA Repair Drugs Sales by Type (2020-2025)
4.1.2 Global Targeting DNA Repair Drugs Sales by Type (2026-2031)
4.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Type (2020-2031)
4.2 Global Targeting DNA Repair Drugs Revenue by Type (2020-2031)
4.2.1 Global Targeting DNA Repair Drugs Revenue by Type (2020-2025)
4.2.2 Global Targeting DNA Repair Drugs Revenue by Type (2026-2031)
4.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Targeting DNA Repair Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Targeting DNA Repair Drugs Sales by Application (2020-2031)
5.1.1 Global Targeting DNA Repair Drugs Sales by Application (2020-2025)
5.1.2 Global Targeting DNA Repair Drugs Sales by Application (2026-2031)
5.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Application (2020-2031)
5.2 Global Targeting DNA Repair Drugs Revenue by Application (2020-2031)
5.2.1 Global Targeting DNA Repair Drugs Revenue by Application (2020-2025)
5.2.2 Global Targeting DNA Repair Drugs Revenue by Application (2026-2031)
5.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Targeting DNA Repair Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Onxeo
6.1.1 Onxeo Company Information
6.1.2 Onxeo Description and Business Overview
6.1.3 Onxeo Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Onxeo Targeting DNA Repair Drugs Product Portfolio
6.1.5 Onxeo Recent Developments/Updates
6.2 FoRx Therapeutics
6.2.1 FoRx Therapeutics Company Information
6.2.2 FoRx Therapeutics Description and Business Overview
6.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.2.5 FoRx Therapeutics Recent Developments/Updates
6.3 Artios Pharma Limited
6.3.1 Artios Pharma Limited Company Information
6.3.2 Artios Pharma Limited Description and Business Overview
6.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolio
6.3.5 Artios Pharma Limited Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck KGaA Targeting DNA Repair Drugs Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Breakpoint Therapeutics
6.5.1 Breakpoint Therapeutics Company Information
6.5.2 Breakpoint Therapeutics Description and Business Overview
6.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.5.5 Breakpoint Therapeutics Recent Developments/Updates
6.6 Luciole Pharmaceuticals
6.6.1 Luciole Pharmaceuticals Company Information
6.6.2 Luciole Pharmaceuticals Description and Business Overview
6.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolio
6.6.5 Luciole Pharmaceuticals Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Targeting DNA Repair Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Company Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AbbVie Targeting DNA Repair Drugs Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Targeting DNA Repair Drugs Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Targeting DNA Repair Drugs Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 ClovisOncology
6.11.1 ClovisOncology Company Information
6.11.2 ClovisOncology Description and Business Overview
6.11.3 ClovisOncology Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ClovisOncology Targeting DNA Repair Drugs Product Portfolio
6.11.5 ClovisOncology Recent Developments/Updates
6.12 GlaxoSmithKline
6.12.1 GlaxoSmithKline Company Information
6.12.2 GlaxoSmithKline Description and Business Overview
6.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolio
6.12.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeting DNA Repair Drugs Industry Chain Analysis
7.2 Targeting DNA Repair Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeting DNA Repair Drugs Production Mode & Process Analysis
7.4 Targeting DNA Repair Drugs Sales and Marketing
7.4.1 Targeting DNA Repair Drugs Sales Channels
7.4.2 Targeting DNA Repair Drugs Distributors
7.5 Targeting DNA Repair Drugs Customer Analysis
8 Targeting DNA Repair Drugs Market Dynamics
8.1 Targeting DNA Repair Drugs Industry Trends
8.2 Targeting DNA Repair Drugs Market Drivers
8.3 Targeting DNA Repair Drugs Market Challenges
8.4 Targeting DNA Repair Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Targeting DNA Repair Drugs by Type
1.2.1 Global Targeting DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Olaparib
1.2.3 Rucaparib
1.2.4 Niraparib
1.2.5 Talazoparib
1.2.6 Others
1.3 Targeting DNA Repair Drugs by Application
1.3.1 Global Targeting DNA Repair Drugs Market Value by Application (2024 VS 2031)
1.3.2 Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Peritoneal Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Targeting DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global Targeting DNA Repair Drugs Revenue 2020-2031
1.4.2 Global Targeting DNA Repair Drugs Sales 2020-2031
1.4.3 Global Targeting DNA Repair Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Targeting DNA Repair Drugs Market Competition by Manufacturers
2.1 Global Targeting DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Targeting DNA Repair Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Targeting DNA Repair Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Targeting DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Targeting DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Targeting DNA Repair Drugs, Product Type & Application
2.7 Global Key Manufacturers of Targeting DNA Repair Drugs, Date of Enter into This Industry
2.8 Global Targeting DNA Repair Drugs Market Competitive Situation and Trends
2.8.1 Global Targeting DNA Repair Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Targeting DNA Repair Drugs Players Market Share by Revenue
2.8.3 Global Targeting DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Targeting DNA Repair Drugs Market Scenario by Region
3.1 Global Targeting DNA Repair Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Targeting DNA Repair Drugs Sales by Region: 2020-2031
3.2.1 Global Targeting DNA Repair Drugs Sales by Region: 2020-2025
3.2.2 Global Targeting DNA Repair Drugs Sales by Region: 2026-2031
3.3 Global Targeting DNA Repair Drugs Revenue by Region: 2020-2031
3.3.1 Global Targeting DNA Repair Drugs Revenue by Region: 2020-2025
3.3.2 Global Targeting DNA Repair Drugs Revenue by Region: 2026-2031
3.4 North America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.4.3 North America Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeting DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.5.3 Europe Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeting DNA Repair Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Targeting DNA Repair Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Targeting DNA Repair Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeting DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.7.3 Latin America Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Targeting DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeting DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeting DNA Repair Drugs Sales by Type (2020-2031)
4.1.1 Global Targeting DNA Repair Drugs Sales by Type (2020-2025)
4.1.2 Global Targeting DNA Repair Drugs Sales by Type (2026-2031)
4.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Type (2020-2031)
4.2 Global Targeting DNA Repair Drugs Revenue by Type (2020-2031)
4.2.1 Global Targeting DNA Repair Drugs Revenue by Type (2020-2025)
4.2.2 Global Targeting DNA Repair Drugs Revenue by Type (2026-2031)
4.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Targeting DNA Repair Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Targeting DNA Repair Drugs Sales by Application (2020-2031)
5.1.1 Global Targeting DNA Repair Drugs Sales by Application (2020-2025)
5.1.2 Global Targeting DNA Repair Drugs Sales by Application (2026-2031)
5.1.3 Global Targeting DNA Repair Drugs Sales Market Share by Application (2020-2031)
5.2 Global Targeting DNA Repair Drugs Revenue by Application (2020-2031)
5.2.1 Global Targeting DNA Repair Drugs Revenue by Application (2020-2025)
5.2.2 Global Targeting DNA Repair Drugs Revenue by Application (2026-2031)
5.2.3 Global Targeting DNA Repair Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Targeting DNA Repair Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Onxeo
6.1.1 Onxeo Company Information
6.1.2 Onxeo Description and Business Overview
6.1.3 Onxeo Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Onxeo Targeting DNA Repair Drugs Product Portfolio
6.1.5 Onxeo Recent Developments/Updates
6.2 FoRx Therapeutics
6.2.1 FoRx Therapeutics Company Information
6.2.2 FoRx Therapeutics Description and Business Overview
6.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.2.5 FoRx Therapeutics Recent Developments/Updates
6.3 Artios Pharma Limited
6.3.1 Artios Pharma Limited Company Information
6.3.2 Artios Pharma Limited Description and Business Overview
6.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Product Portfolio
6.3.5 Artios Pharma Limited Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck KGaA Targeting DNA Repair Drugs Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Breakpoint Therapeutics
6.5.1 Breakpoint Therapeutics Company Information
6.5.2 Breakpoint Therapeutics Description and Business Overview
6.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Product Portfolio
6.5.5 Breakpoint Therapeutics Recent Developments/Updates
6.6 Luciole Pharmaceuticals
6.6.1 Luciole Pharmaceuticals Company Information
6.6.2 Luciole Pharmaceuticals Description and Business Overview
6.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product Portfolio
6.6.5 Luciole Pharmaceuticals Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Targeting DNA Repair Drugs Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Company Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AbbVie Targeting DNA Repair Drugs Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Targeting DNA Repair Drugs Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Targeting DNA Repair Drugs Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 ClovisOncology
6.11.1 ClovisOncology Company Information
6.11.2 ClovisOncology Description and Business Overview
6.11.3 ClovisOncology Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ClovisOncology Targeting DNA Repair Drugs Product Portfolio
6.11.5 ClovisOncology Recent Developments/Updates
6.12 GlaxoSmithKline
6.12.1 GlaxoSmithKline Company Information
6.12.2 GlaxoSmithKline Description and Business Overview
6.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Product Portfolio
6.12.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeting DNA Repair Drugs Industry Chain Analysis
7.2 Targeting DNA Repair Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeting DNA Repair Drugs Production Mode & Process Analysis
7.4 Targeting DNA Repair Drugs Sales and Marketing
7.4.1 Targeting DNA Repair Drugs Sales Channels
7.4.2 Targeting DNA Repair Drugs Distributors
7.5 Targeting DNA Repair Drugs Customer Analysis
8 Targeting DNA Repair Drugs Market Dynamics
8.1 Targeting DNA Repair Drugs Industry Trends
8.2 Targeting DNA Repair Drugs Market Drivers
8.3 Targeting DNA Repair Drugs Market Challenges
8.4 Targeting DNA Repair Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Targeting DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Targeting DNA Repair Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Targeting DNA Repair Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Targeting DNA Repair Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Targeting DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Targeting DNA Repair Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Targeting DNA Repair Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Targeting DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Targeting DNA Repair Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Targeting DNA Repair Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Targeting DNA Repair Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeting DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeting DNA Repair Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeting DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Targeting DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Targeting DNA Repair Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Targeting DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Targeting DNA Repair Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Targeting DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Targeting DNA Repair Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Targeting DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Targeting DNA Repair Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Targeting DNA Repair Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Targeting DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Targeting DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Targeting DNA Repair Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Targeting DNA Repair Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Targeting DNA Repair Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Targeting DNA Repair Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Targeting DNA Repair Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Targeting DNA Repair Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Targeting DNA Repair Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Targeting DNA Repair Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Onxeo Company Information
Table 71. Onxeo Description and Business Overview
Table 72. Onxeo Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Onxeo Targeting DNA Repair Drugs Product
Table 74. Onxeo Recent Developments/Updates
Table 75. FoRx Therapeutics Company Information
Table 76. FoRx Therapeutics Description and Business Overview
Table 77. FoRx Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. FoRx Therapeutics Targeting DNA Repair Drugs Product
Table 79. FoRx Therapeutics Recent Developments/Updates
Table 80. Artios Pharma Limited Company Information
Table 81. Artios Pharma Limited Description and Business Overview
Table 82. Artios Pharma Limited Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Artios Pharma Limited Targeting DNA Repair Drugs Product
Table 84. Artios Pharma Limited Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck KGaA Targeting DNA Repair Drugs Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Breakpoint Therapeutics Company Information
Table 91. Breakpoint Therapeutics Description and Business Overview
Table 92. Breakpoint Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Breakpoint Therapeutics Targeting DNA Repair Drugs Product
Table 94. Breakpoint Therapeutics Recent Developments/Updates
Table 95. Luciole Pharmaceuticals Company Information
Table 96. Luciole Pharmaceuticals Description and Business Overview
Table 97. Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Luciole Pharmaceuticals Targeting DNA Repair Drugs Product
Table 99. Luciole Pharmaceuticals Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. AstraZeneca Targeting DNA Repair Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. AbbVie Company Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. AbbVie Targeting DNA Repair Drugs Product
Table 109. AbbVie Recent Developments/Updates
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Johnson & Johnson Targeting DNA Repair Drugs Product
Table 114. Johnson & Johnson Recent Developments/Updates
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Pfizer Targeting DNA Repair Drugs Product
Table 119. Pfizer Recent Developments/Updates
Table 120. ClovisOncology Company Information
Table 121. ClovisOncology Description and Business Overview
Table 122. ClovisOncology Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. ClovisOncology Targeting DNA Repair Drugs Product
Table 124. ClovisOncology Recent Developments/Updates
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. GlaxoSmithKline Targeting DNA Repair Drugs Product
Table 129. GlaxoSmithKline Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Targeting DNA Repair Drugs Distributors List
Table 133. Targeting DNA Repair Drugs Customers List
Table 134. Targeting DNA Repair Drugs Market Trends
Table 135. Targeting DNA Repair Drugs Market Drivers
Table 136. Targeting DNA Repair Drugs Market Challenges
Table 137. Targeting DNA Repair Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeting DNA Repair Drugs
Figure 2. Global Targeting DNA Repair Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeting DNA Repair Drugs Market Share by Type: 2024 & 2031
Figure 4. Olaparib Product Picture
Figure 5. Rucaparib Product Picture
Figure 6. Niraparib Product Picture
Figure 7. Talazoparib Product Picture
Figure 8. Others Product Picture
Figure 9. Global Targeting DNA Repair Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Targeting DNA Repair Drugs Market Share by Application: 2024 & 2031
Figure 11. Ovarian Cancer
Figure 12. Fallopian Tube Cancer
Figure 13. Peritoneal Cancer
Figure 14. Breast Cancer
Figure 15. Others
Figure 16. Global Targeting DNA Repair Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Targeting DNA Repair Drugs Market Size (2020-2031) & (US$ Million)
Figure 18. Global Targeting DNA Repair Drugs Sales (2020-2031) & (K Units)
Figure 19. Global Targeting DNA Repair Drugs Average Price (US$/Unit) & (2020-2031)
Figure 20. Targeting DNA Repair Drugs Report Years Considered
Figure 21. Targeting DNA Repair Drugs Sales Share by Manufacturers in 2024
Figure 22. Global Targeting DNA Repair Drugs Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Targeting DNA Repair Drugs Players: Market Share by Revenue in Targeting DNA Repair Drugs in 2024
Figure 24. Targeting DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Targeting DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 27. North America Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 28. United States Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 31. Europe Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 32. Germany Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Targeting DNA Repair Drugs Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Targeting DNA Repair Drugs Revenue Market Share by Region (2020-2031)
Figure 39. China Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 47. Latin America Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Targeting DNA Repair Drugs by Type (2020-2031)
Figure 57. Global Revenue Market Share of Targeting DNA Repair Drugs by Type (2020-2031)
Figure 58. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Targeting DNA Repair Drugs by Application (2020-2031)
Figure 60. Global Revenue Market Share of Targeting DNA Repair Drugs by Application (2020-2031)
Figure 61. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2020-2031)
Figure 62. Targeting DNA Repair Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Targeting DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Targeting DNA Repair Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Targeting DNA Repair Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Targeting DNA Repair Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Targeting DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Targeting DNA Repair Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Targeting DNA Repair Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Targeting DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Targeting DNA Repair Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Targeting DNA Repair Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Targeting DNA Repair Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeting DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeting DNA Repair Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeting DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Targeting DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Targeting DNA Repair Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Targeting DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Targeting DNA Repair Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Targeting DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Targeting DNA Repair Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Targeting DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Targeting DNA Repair Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Targeting DNA Repair Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Targeting DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Targeting DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Targeting DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Targeting DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Targeting DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Targeting DNA Repair Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Targeting DNA Repair Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Targeting DNA Repair Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Targeting DNA Repair Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Targeting DNA Repair Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Targeting DNA Repair Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Targeting DNA Repair Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Targeting DNA Repair Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Targeting DNA Repair Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Targeting DNA Repair Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Targeting DNA Repair Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Onxeo Company Information
Table 71. Onxeo Description and Business Overview
Table 72. Onxeo Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Onxeo Targeting DNA Repair Drugs Product
Table 74. Onxeo Recent Developments/Updates
Table 75. FoRx Therapeutics Company Information
Table 76. FoRx Therapeutics Description and Business Overview
Table 77. FoRx Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. FoRx Therapeutics Targeting DNA Repair Drugs Product
Table 79. FoRx Therapeutics Recent Developments/Updates
Table 80. Artios Pharma Limited Company Information
Table 81. Artios Pharma Limited Description and Business Overview
Table 82. Artios Pharma Limited Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Artios Pharma Limited Targeting DNA Repair Drugs Product
Table 84. Artios Pharma Limited Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck KGaA Targeting DNA Repair Drugs Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Breakpoint Therapeutics Company Information
Table 91. Breakpoint Therapeutics Description and Business Overview
Table 92. Breakpoint Therapeutics Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Breakpoint Therapeutics Targeting DNA Repair Drugs Product
Table 94. Breakpoint Therapeutics Recent Developments/Updates
Table 95. Luciole Pharmaceuticals Company Information
Table 96. Luciole Pharmaceuticals Description and Business Overview
Table 97. Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Luciole Pharmaceuticals Targeting DNA Repair Drugs Product
Table 99. Luciole Pharmaceuticals Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. AstraZeneca Targeting DNA Repair Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. AbbVie Company Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. AbbVie Targeting DNA Repair Drugs Product
Table 109. AbbVie Recent Developments/Updates
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Johnson & Johnson Targeting DNA Repair Drugs Product
Table 114. Johnson & Johnson Recent Developments/Updates
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Pfizer Targeting DNA Repair Drugs Product
Table 119. Pfizer Recent Developments/Updates
Table 120. ClovisOncology Company Information
Table 121. ClovisOncology Description and Business Overview
Table 122. ClovisOncology Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. ClovisOncology Targeting DNA Repair Drugs Product
Table 124. ClovisOncology Recent Developments/Updates
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Targeting DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. GlaxoSmithKline Targeting DNA Repair Drugs Product
Table 129. GlaxoSmithKline Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Targeting DNA Repair Drugs Distributors List
Table 133. Targeting DNA Repair Drugs Customers List
Table 134. Targeting DNA Repair Drugs Market Trends
Table 135. Targeting DNA Repair Drugs Market Drivers
Table 136. Targeting DNA Repair Drugs Market Challenges
Table 137. Targeting DNA Repair Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeting DNA Repair Drugs
Figure 2. Global Targeting DNA Repair Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeting DNA Repair Drugs Market Share by Type: 2024 & 2031
Figure 4. Olaparib Product Picture
Figure 5. Rucaparib Product Picture
Figure 6. Niraparib Product Picture
Figure 7. Talazoparib Product Picture
Figure 8. Others Product Picture
Figure 9. Global Targeting DNA Repair Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Targeting DNA Repair Drugs Market Share by Application: 2024 & 2031
Figure 11. Ovarian Cancer
Figure 12. Fallopian Tube Cancer
Figure 13. Peritoneal Cancer
Figure 14. Breast Cancer
Figure 15. Others
Figure 16. Global Targeting DNA Repair Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Targeting DNA Repair Drugs Market Size (2020-2031) & (US$ Million)
Figure 18. Global Targeting DNA Repair Drugs Sales (2020-2031) & (K Units)
Figure 19. Global Targeting DNA Repair Drugs Average Price (US$/Unit) & (2020-2031)
Figure 20. Targeting DNA Repair Drugs Report Years Considered
Figure 21. Targeting DNA Repair Drugs Sales Share by Manufacturers in 2024
Figure 22. Global Targeting DNA Repair Drugs Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Targeting DNA Repair Drugs Players: Market Share by Revenue in Targeting DNA Repair Drugs in 2024
Figure 24. Targeting DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Targeting DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 27. North America Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 28. United States Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 31. Europe Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 32. Germany Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Targeting DNA Repair Drugs Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Targeting DNA Repair Drugs Revenue Market Share by Region (2020-2031)
Figure 39. China Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 47. Latin America Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Targeting DNA Repair Drugs Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Targeting DNA Repair Drugs Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Targeting DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Targeting DNA Repair Drugs by Type (2020-2031)
Figure 57. Global Revenue Market Share of Targeting DNA Repair Drugs by Type (2020-2031)
Figure 58. Global Targeting DNA Repair Drugs Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Targeting DNA Repair Drugs by Application (2020-2031)
Figure 60. Global Revenue Market Share of Targeting DNA Repair Drugs by Application (2020-2031)
Figure 61. Global Targeting DNA Repair Drugs Price (US$/Unit) by Application (2020-2031)
Figure 62. Targeting DNA Repair Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232